EE03140B1 - Fosfolipiidderivaadid - Google Patents

Fosfolipiidderivaadid

Info

Publication number
EE03140B1
EE03140B1 EE9400199A EE9400199A EE03140B1 EE 03140 B1 EE03140 B1 EE 03140B1 EE 9400199 A EE9400199 A EE 9400199A EE 9400199 A EE9400199 A EE 9400199A EE 03140 B1 EE03140 B1 EE 03140B1
Authority
EE
Estonia
Prior art keywords
phospholipid derivatives
derivatives
phospholipid
medicaments
preparation processes
Prior art date
Application number
EE9400199A
Other languages
English (en)
Estonian (et)
Inventor
N�ssner Gerhard
Kutscher Bernhard
Engel J�rgen
Schumacher Wolfgang
Stekar Jurij
Hilgard Peter
Original Assignee
Asta Medica Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Aktiengesellschaft filed Critical Asta Medica Aktiengesellschaft
Publication of EE03140B1 publication Critical patent/EE03140B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/106—Adducts, complexes, salts of phosphatides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532—Seven-(or more) membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Saccharide Compounds (AREA)
EE9400199A 1992-07-11 1994-10-25 Fosfolipiidderivaadid EE03140B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4222910A DE4222910A1 (de) 1992-07-11 1992-07-11 Neue Phospholipidderivate

Publications (1)

Publication Number Publication Date
EE03140B1 true EE03140B1 (et) 1998-12-15

Family

ID=6463031

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400199A EE03140B1 (et) 1992-07-11 1994-10-25 Fosfolipiidderivaadid

Country Status (31)

Country Link
EP (1) EP0579939B1 (lv)
JP (1) JP3311431B2 (lv)
KR (1) KR100297180B1 (lv)
CN (1) CN1039012C (lv)
AT (1) ATE176477T1 (lv)
AU (1) AU664101B2 (lv)
BR (1) BR9302809A (lv)
CA (2) CA2100228C (lv)
CZ (1) CZ290863B6 (lv)
DE (2) DE4222910A1 (lv)
DK (1) DK0579939T3 (lv)
EE (1) EE03140B1 (lv)
ES (1) ES2129053T3 (lv)
FI (1) FI111262B (lv)
GR (1) GR3029602T3 (lv)
HR (1) HRP931046B1 (lv)
HU (1) HU218783B (lv)
IL (1) IL106289A (lv)
LT (1) LT3113B (lv)
LV (1) LV10870B (lv)
MX (1) MX9304133A (lv)
NO (1) NO306468B1 (lv)
PL (3) PL177811B1 (lv)
RU (1) RU2108336C1 (lv)
SG (1) SG46249A1 (lv)
SI (1) SI9300365B (lv)
SK (1) SK283827B6 (lv)
TW (1) TW304956B (lv)
UA (1) UA40567C2 (lv)
YU (1) YU49079B (lv)
ZA (1) ZA934971B (lv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007008810A (es) 2005-01-21 2007-11-21 Astex Therapeutics Ltd Compuestos farmaceuticos.
AR058397A1 (es) * 2005-12-19 2008-01-30 Zentaris Gmbh Derivados de alquilfosfolipidos con citotoxicidad reducida y usos de los mismos
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
EP1869981A1 (de) * 2006-06-21 2007-12-26 Staatliches Weinbauinstitut Freiburg Alkylphospholipide und Lyso-Phospholipide zur Bekämpfung von Pflanzenpathogenen
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444766A (en) * 1980-10-21 1984-04-24 Boehringer Mannheim Gmbh Sulfur-containing phospholipid compounds and therapeutic compositions
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
DE3530767A1 (de) * 1985-08-28 1987-03-12 Max Planck Gesellschaft Mittel gegen multiple sklerose
IE59777B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicaments
DE3765502D1 (de) * 1986-07-14 1990-11-15 Nippon Chemiphar Co Glycerolderivat und antihypertensives mittel.
CN1017435B (zh) * 1987-03-24 1992-07-15 日本化学医药株式会社 新的甘油衍生物的制备方法
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
DE3942933A1 (de) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh Verwendung von alkylphospholipiden als antivirale arzneimittel und neue phospholipid-derivate
DE4114586A1 (de) * 1991-05-04 1992-11-05 Boehringer Mannheim Gmbh Arzneimittel enthaltend azacyclodiphosphonsaeurederivate, neue azacyclodiphosphonsaeurederivate sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
CA2100228C (en) 2006-01-24
KR940002265A (ko) 1994-02-17
ATE176477T1 (de) 1999-02-15
HRP931046B1 (en) 2000-06-30
DE4222910A1 (de) 1994-01-13
KR100297180B1 (ko) 2001-11-30
PL177811B1 (pl) 2000-01-31
EP0579939B1 (de) 1999-02-03
SK67093A3 (en) 1995-03-08
FI933165A (fi) 1994-01-12
CZ290863B6 (cs) 2002-11-13
SI9300365A (en) 1994-03-31
CN1084175A (zh) 1994-03-23
NO932502D0 (no) 1993-07-08
FI933165A0 (fi) 1993-07-09
YU49079B (sh) 2003-08-29
IL106289A (en) 2000-06-01
NO306468B1 (no) 1999-11-08
FI111262B (fi) 2003-06-30
LT3113B (en) 1994-12-27
SG46249A1 (en) 1998-02-20
ES2129053T3 (es) 1999-06-01
HUT64548A (en) 1994-01-28
SK283827B6 (sk) 2004-02-03
CZ124993A3 (en) 1995-03-15
CA2100228A1 (en) 1994-01-12
RU2108336C1 (ru) 1998-04-10
PL175607B1 (pl) 1999-01-29
JPH0733791A (ja) 1995-02-03
HRP931046A2 (en) 1997-04-30
AU664101B2 (en) 1995-11-02
HU9301992D0 (en) 1993-09-28
LV10870A (lv) 1995-10-20
NO932502L (no) 1994-01-12
YU47393A (sh) 1997-08-22
CA2511753A1 (en) 1994-01-12
PL173388B1 (pl) 1998-02-27
EP0579939A1 (de) 1994-01-26
DK0579939T3 (da) 1999-09-20
LTIP620A (en) 1994-07-15
PL299624A1 (en) 1994-02-21
SI9300365B (sl) 2002-02-28
LV10870B (en) 1996-06-20
AU4186493A (en) 1994-01-13
IL106289A0 (en) 1994-04-12
CA2511753C (en) 2007-09-25
HU218783B (hu) 2000-12-28
DE59309355D1 (de) 1999-03-18
TW304956B (lv) 1997-05-11
ZA934971B (en) 1994-02-01
MX9304133A (es) 1994-04-29
UA40567C2 (uk) 2001-08-15
CN1039012C (zh) 1998-07-08
GR3029602T3 (en) 1999-06-30
JP3311431B2 (ja) 2002-08-05
BR9302809A (pt) 1994-03-15

Similar Documents

Publication Publication Date Title
ATE494009T1 (de) Prodrugs, ihre herstellung und verwendung als arzneimittel
PT83872A (de) Arzneimittel
DE68920455D1 (de) Cyclohexenderivate.
ES544787A0 (es) Preparaciones medicinales solidas
DK0579939T3 (da) Phospholipidderivater
DE58902310D1 (de) Tetrahydropyridin-derivate.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
ATE66481T1 (de) Pyranobenzoxadiazolderivate, herstellung, verwendung und diese enthaltende zubereitungen.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20051231

HE1A Change of address
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20101231